|
1
|
Türkvatan A, Erden A, Türkoğlu MA, Seçil M
and Yener Ö: Imaging of acute pancreatitis and its complications.
Part 1 Acute pancreatitis. Diagn Interv Imaging. 96:151–160. 2015.
View Article : Google Scholar
|
|
2
|
Kuramatsu JB, Huttner HB and Schwab S:
Advances in the management of intracerebral hemorrhage. J Neural
Transm (Vienna). 120 Suppl 1:S35–S41. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yadav D and Lowenfels AB: The epidemiology
of pancreatitis and pancreatic cancer. Gastroenterology.
144:1252–1261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maheshwari R and Subramanian RM: Severe
acute pancreatitis and necrotizing pancreatitis. Crit Care Clin.
32:279–290. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang ZW, Meng XX and Xu P: Central role of
neutrophil in the pathogenesis of severe acute pancreatitis. J Cell
Mol Med. 19:2513–2520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sternby H, Hartman H, Johansen D,
Thorlacius H and Regner S: Predictive capacity of biomarkers for
severe acute pancreatitis. Eur Surg Res. 56:154–163. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu R, Qi H, Wang J, Wang Y, Cui L, Wen Y
and Yin C: Ulinastatin activates the renin-angiotensin system to
ameliorate the pathophysiology of severe acute pancreatitis. J
Gastroenterol Hepatol. 29:1328–1337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen S, Shi H, Zou X and Luo H: Role of
ulinastatin in preventing post-endoscopic retrograde
cholangiopancreatography pancreatitis: The Emperor's new clothes or
aladdin's magic lamp? Pancreas. 39:1231–1237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jia R, Tang M, Qiu L, Sun R, Cheng L, Ma
X, Yin G, Hu G, Wang X and Zhao Y: Increased interleukin-23/17 axis
and C-reactive protein are associated with severity of acute
pancreatitis in patients. Pancreas. 44:321–325. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gurleyik G, Emir S, Kilicoglu G, Arman A
and Saglam A: Computed tomography severity index, APACHE II score,
and serum CRP concentration for predicting the severity of acute
pancreatitis. JOP. 6:562–567. 2005.PubMed/NCBI
|
|
11
|
Ansar W and Ghosh S: C-reactive protein
and the biology of disease. Immunol Res. 56:131–142. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Allin KH and Nordestgaard BG: Elevated
C-reactive protein in the diagnosis, prognosis, and cause of
cancer. Crit Rev Clin Lab Sci. 48:155–170. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh PP, Zeng IS, Srinivasa S, Lemanu DP,
Connolly AB and Hill AG: Systematic review and meta-analysis of use
of serum C-reactive protein levels to predict anastomotic leak
after colorectal surgery. Br J Surg. 101:339–346. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sato T, Ohno K, Tamamoto T, Oishi M,
Kanemoto H, Fukushima K, Goto-Koshino Y, Takahashi M and Tsujimoto
H: Assesment of severity and changes in C-reactive protein
concentration and various biomarkers in dogs with pancreatitis. J
Vet Med Sci. 79:35–40. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tachyla SA, Marochkov AV, Lipnitski AL and
Nikiforova YG: The prognostic value of procalcitonin, C-reactive
protein and cholesterol in patients with an infection and multiple
organ dysfunction. Korean J Anesthesiol. 70:305–310. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pongprasobchai S, Jianjaroonwong V,
Charatcharoenwitthaya P, Komoltri C, Tanwandee T, Leelakusolvong S,
Pausawasdi N, Srikureja W, Chainuvati S, Prachayakul V, et al:
Erythrocyte sedimentation rate and C-reactive protein for the
prediction of severity of acute pancreatitis. Pancreas.
39:1226–1230. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Loveday BP, Srinivasa S, Vather R, Mittal
A, Petrov MS, Phillips AR and Windsor JA: High quantity and
variable quality of guidelines for acute pancreatitis: A systematic
review. Am J Gastroenterol. 105:1466–1476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsuji Y, Takahashi N and Tsutomu C:
Pancreatic perfusion CT in early stage of severe acute
pancreatitis. Int J Inflam. 2012:4973862012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reintam A, Parm P, Kitus R, Starkopf J and
Kern H: Gastrointestinal failure score in critically ill patients:
A prospective observational study. Crit Care. 12:R902008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang G, Wen J, Wilbur RR, Wen P, Zhou SF
and Xiao X: The effect of somatostatin, ulinastatin and Salvia
miltiorrhiza on severe acute pancreatitis treatment. Am J Med Sci.
346:371–376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoo YW, Cha SW, Kim A, Na SY, Lee YW, Kim
SH, Lee HIe, Lee YJ, Yang HW and Jung SH: The use of gabexate
mesylate and ulinastatin for the prevention of post-endoscopic
retrograde cholangiopancreatography pancreatitis. Gut Liver.
6:256–261. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yin G, Hu G, Cang X, Yu G, Hu Y, Xing M,
Chen C, Huang Y, Tang M, Zhao Y, et al: C-reactive protein:
Rethinking its role in evaluating the severity of hyperlipidemic
acute pancreatitis. Pancreas. 43:1323–1328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mroczko B, Groblewska M, Gryko M, Kedra B
and Szmitkowski M: Diagnostic usefulness of serum interleukin 6
(IL-6) and C-reactive protein (CRP) in the differentiation between
pancreatic cancer and chronic pancreatitis. J Clin Lab Anal.
24:256–261. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schütte K and Malfertheiner P: Markers for
predicting severity and progression of acute pancreatitis. Best
Pract Res Clin Gastroenterol. 22:75–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang C, Wang Y, Fu W, Zhang W, Wang T and
Qin H: A Meta-analysis on the effect of ulinastatin on serum levels
of C-reactive protein, interleukin 6, and tumor necrosis factor
alpha in Asian patients with acute pancreatitis. Genet Test Mol
Biomarkers. 20:118–124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vermeire S, Van Assche G and Rutgeerts P:
The role of C-reactive protein as an inflammatory marker in
gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol.
2:580–586. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cardoso FS, Ricardo L, Gondar P, Deus JR
and Horta D: C-reactive protein may influence decisively the
prescription of prophylactic antibiotics in acute pancreatitis: A
population-based cohort study. Pancreas. 44:404–408.
2015.PubMed/NCBI
|
|
28
|
Wang X, Zhuang X, Wei R, Wang C, Xue X and
Mao L: Protective effects of Acanthopanax vs. Ulinastatin against
severe acute pancreatitis-induced brain injury in rats. Int
Immunopharmacol. 24:285–298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shen Y, Cui N, Miao B and Zhao E: Immune
dysregulation in patients with severe acute pancreatitis.
Inflammation. 34:36–42. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang G, Liu Y, Zhou SF, Qiu P, Xu L, Wen
P, Wen J and Xiao X: Effect of Somatostatin, Ulinastatin and
gabexate on the treatment of severe acute pancreatitis. Am J Med
Sci. 351:506–512. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reinisch W, Wang Y, Oddens BJ and Link R:
C-reactive protein, an indicator for maintained response or
remission to infliximab in patients with Crohn's disease: A
post-hoc analysis from ACCENT I. Aliment Pharmacol Ther.
35:568–576. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Muddana V, Whitcomb DC, Khalid A, Slivka A
and Papachristou GI: Elevated serum creatinine as a marker of
pancreatic necrosis in acute pancreatitis. Am J Gastroenterol.
104:164–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Y, Zhang ZW, Wang B, Yin WH, Zuo YY,
Kang Y and Liu J: Relationship between early serum albumin
variation and prognosis in patients with severe acute pancreatitis
treated in ICU. Sichuan Da Xue Xue Bao Yi Xue Ban. 44:237–241.
2013.(In Chinese). PubMed/NCBI
|
